- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04571723
Health Mindset as a Driver of Efficacy of a Diabetes Prevention Program in the Blackfeet Community
April 4, 2022 updated by: Montana State University
The overall goal of this project is to understand whether the established Diabetes prevention program works to reduce diabetes risk by shifting mindsets about health.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The Diabetes Prevention Program (DPP), a lifestyle intervention which aims to modify health behaviors, has reduced diabetes risk across several American Indian Communities.
However, there were significant attrition rates, and non-completers were at the highest risk at baseline.
One's mindset about health (i.e.
whether it is fixed or malleable) may affect their likelihood of completing the intervention and its efficacy in reducing risk.
With an existing CAB, I will develop a culturally congruent adaptation of the DPP, the Mindset-DPP (M-DPP).
The M-DPP will include a discussion of mindset in each session and will present material focused on the plasticity of health, including evidence that one's mindset can affect outcomes that relate to risk for diabetes.
The investigators will implement the DPP and the MDPP in a sample of 40 Blackfeet community members at risk for diabetes and test whether the M-DPP associates with greater shifts towards a growth health mindsets (i.e.
health can be changed by effort) compared to the DPP, and whether the M-DPP associates with greater increases in physical activity levels and greater reductions in waist circumference, and greater retention compared to the standard DPP.
Study Type
Interventional
Enrollment (Actual)
24
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Montana
-
Browning, Montana, United States, 59417
- Blackfeet Community College
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- self identified as American Indian
- identified as high risk for diabetes based on the American Diabetes Association paper and pencil test
- must reside on the Blackfeet reservation
Exclusion Criteria:
-chronic disease diagnosis
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Established Diabetes Prevention Program
This arm will receive the established diabetes prevention program curriculum.
|
This is the established Diabetes prevention program curriculum.
|
Active Comparator: Health Mindset modified Diabetes Prevention Program
This arm will receive the modified curriculum with the added health mindset information.
|
This is the established diabetes prevention program curriculum with the addition of curriculum focused on the role of mindset in health.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Health Mindset
Time Frame: baseline, 6 weeks after baseline, and immediately after the intervention (11 weeks after baseline)
|
The Health Mindset Questionnaire will be used to measure the degree to which participants view health as fixed or modifiable.
Higher scores on the scale reflect a stronger growth health mindset (i.e.
health can be changed) while lower numbers reflect a more fixed health mindset (i.e.
health is not modifiable).
The range of possible scores is 3-18.
Change will be calculated from subtracting the health mindset score will be calculated by subtracting the health mindset score at baseline from subsequent health mindset scores (2 change scores will be calculated: one at 6 weeks after baseline and one at 11 weeks after baseline).
|
baseline, 6 weeks after baseline, and immediately after the intervention (11 weeks after baseline)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
physical activity levels
Time Frame: during the intervention, up to 11 weeks.
|
accelerometer derived measure of average physical activity levels
|
during the intervention, up to 11 weeks.
|
waist circumference
Time Frame: baseline, 6 weeks after baseline, and immediately after the intervention (11 weeks after baseline)
|
circumference of the waist will be measured
|
baseline, 6 weeks after baseline, and immediately after the intervention (11 weeks after baseline)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2021
Primary Completion (Actual)
January 30, 2022
Study Completion (Actual)
March 30, 2022
Study Registration Dates
First Submitted
September 17, 2020
First Submitted That Met QC Criteria
September 25, 2020
First Posted (Actual)
October 1, 2020
Study Record Updates
Last Update Posted (Actual)
April 5, 2022
Last Update Submitted That Met QC Criteria
April 4, 2022
Last Verified
September 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 18-13
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus, Type 2
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Mannkind CorporationTerminatedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
Griffin HospitalCalifornia Walnut CommissionCompletedDIABETES MELLITUS TYPE 2United States
-
RWTH Aachen UniversityBoehringer IngelheimCompletedDiabetes Mellitus Type 2 (T2DM)Germany
-
Scripps Whittier Diabetes InstituteSan Diego State UniversityCompletedType 2 Diabetes Mellitus (T2DM)United States
-
AstraZenecaRecruiting
-
Daewoong Pharmaceutical Co. LTD.Not yet recruitingT2DM (Type 2 Diabetes Mellitus)
-
Zhongda HospitalRecruitingType 2 Diabetes Mellitus (T2DM)China
-
Newsoara Biopharma Co., Ltd.RecruitingT2DM (Type 2 Diabetes Mellitus)China
-
Shanghai Golden Leaf MedTec Co. LtdActive, not recruitingType 2 Diabetes Mellitus (T2DM)China
Clinical Trials on Diabetes Prevention Program
-
Baylor Research InstituteUniversity of North Texas Health Science CenterCompletedObesity | Pre-diabetesUnited States
-
The University of Texas Medical Branch, GalvestonWithdrawnHypertension | Prediabetic State | Overweight or Obesity | Gestational Weight Gain
-
Norwegian University of Science and TechnologyKathmandu University School of Medical SciencesCompleted
-
Johns Hopkins UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingHyperglycemia | Obesity | Overweight | Weight Loss | PreDiabetes | Prediabetic State | Impaired Glucose Tolerance | Glucose, High Blood | Lifestyle, Healthy | Lifestyle Risk Reduction | Lifestyle, SedentaryUnited States
-
Washington State UniversityCompletedDiabetesUnited States
-
Washington State UniversityCompleted
-
University of Kansas Medical CenterKansas State University; National Institute of General Medical Sciences (NIGMS)CompletedWeight Loss | PreDiabetes | Lifestyle Risk ReductionUnited States
-
Johns Hopkins UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedPreDiabetes | Type 2 Diabetes | Obesity, Childhood | Overweight and Obesity | Lifestyle, Healthy | Overweight, ChildhoodUnited States
-
Ohio UniversityTouro University, CaliforniaCompletedPreDiabetes
-
Kaiser PermanenteCompletedObesity | Diabetes Mellitus, Type 2 | OverweightUnited States